Infant B cell responses to polysaccharide determinants

Vaccine

Volumn 16, Issue 14-15, 1998, Pages 1396-1400

  Rijkers, G T ^a   Sanders, E A M ^a   Breukels, M A ^a   Zegers, B J M ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL POLYSACCHARIDE; COMPLEMENT COMPONENT C3D RECEPTOR; EPITOPE; IMMUNOGLOBULIN G2;

ANTIBODY RESPONSE; ANTIGEN EXPRESSION; B LYMPHOCYTE; BACTERIAL INFECTION; BACTERIAL MEMBRANE; CHILD CARE; COMPLEMENT ACTIVATION; CONFERENCE PAPER; HOST SUSCEPTIBILITY; HUMAN; HUMORAL IMMUNITY; INFANT; LYMPHOCYTE ACTIVATION; NEWBORN; PRESCHOOL CHILD; PRIORITY JOURNAL; VACCINATION;

B-LYMPHOCYTES; CHILD, PRESCHOOL; EPITOPES; HUMANS; INFANT; INFANT, NEWBORN; LYMPHOCYTE ACTIVATION; POLYSACCHARIDES, BACTERIAL;

EID: 0032147015     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(98)00098-X     Document Type: Conference Paper

References (44)

1. 1 Pabst, H.F. and Kreth, H.W. Ontogeny of the immune response as a basis of childhood disease. J. Ped. 1980, 97, 519-527.
2. 2 Wald, E.R., Guerra, N. and Byers, C. Upper respiratory tract infections in young children: duration of and frequency of complications. Pediatrics 1991, 87, 129-133.
3. 3 Gray, B.M. and Dillon, H.C. Clinical and epidemiological studies of pneumococcal infection in children. Ped. Infect. Dis. 1986, 5, 201-207.
4. 4 Klein, J.O. The epidemiology of pneumococcal disease in infants and children. Rev. Infect. Dis. 1981, 3, 246-253.
5. 5 Gathings, W.E., Kubagawa, H. and Cooper, M.D. A distinctive pattern of B cell immaturity in perinatal humans. Immunol. Rev. 1981, 57, 107-126.
6. 6 Hayward, A.R. and Lawton, A.R. Induction of plasma cell differentiation of human fetal lymphocytes: evidence for immaturity of T and B cells. J. Immunol. 1977, 119, 1213-1217.
7. 7 Splawski, J. and Lipsky, P. Delineation of the functional capacity of human neonatal lymphocytes. J. Clin. Invest. 1991, 87, 545-553.
8. 8 Noelle, R.J., Ledbetter, J.A. and Aruffo, A. CD40 and its ligand, an essential ligand-receptor pair for thymus-dependent B-cell activation. Immunol. Today 1992, 13, 431-433.
9. 9 Nonoyama, S., Penix, L.A., Edwards, C.P., Lewis, D.B., Ito, S., Aruffo, Wilson, C.B. and Ochs, H.D. Diminished expression of CD40 ligand by activated neonatal T cells. J. Clin. Invest. 1995, 95, 66-75.
10. 10 Durandy, A., De Saint Basille, G., Lisowska-Grospierre, B., Gauchat, J.F., Forveille, M., Kroczek, R.A., Bonnefoy, J.Y. and Fischer, A. Undetectable CD40 ligand expression on T cells and low B cell responses to CD40 binding agonists in human newborns. J. Immunol. 1995, 154, 1560-1568.
11. 11 Splawski, J.B., Nishioka, J., Nishioka, Y. and Lipsky, P.E. CD40 ligand is expressed and functional on activated neonatal T cells. J. Immunol. 1996, 156, 119-127.
12. 12 Mosier, D.E. and Subarrao, B. Thymus-independent antigens: complexity of B-lymphocyte activation revealed, Immunol. Today 1982, 3, 217-222.
13. 13 Käyhty, H., Karanko, V., Peltola, H. and Mäkelä, P.H. Serum antibodies after vaccination with Haemophilus influenzae type b capsular polysaccharide and responses to reimmunization: no evidence of immunologic tolerance or memory. Pediatrics 1984, 74, 857-865.
14. 14 Insel, R.A., Kittelberger, A. and Anderson, P. Isoelectric focusing of human antibody to the Haemophilus influenzae b capsular polysaccharide: restricted and identical spectrotypes in adults. J. Immunol. 1985, 135, 2810-2816.
15. 15 Herrmann, D.J., Hamilton, R.G., Barington, T., Frasch, C.E., Arakere, G., Mäkelä, O., Mitchell, L.A., Nagel, J., Rijkers, G.T., Zegers, B., Danve, B., Ward, J.I. and Brown, C.S. Quantitation of human IgG subclass antibodies to Haemophilus influenzae type b capsular polysaccharide. J. Immunol. Meth. 1992, 148, 101-114.
16. L families. J. Immunol. 1989, 143, 293-298.
17. 17 Griffioen, A.W., Toebes, E.A.H., Rijkers, G.T., Claas, F.H.J., Dataman, G. and Zegers, B.J.M. The amplifier role of T cells in the human in vitro B cell response to type 4 pneumococcal polysaccharide. Immunol. Lett. 1992, 32, 265-272.
18. 18 Rijkers, G.T. and Mosier, D.E. Pneumococcal polysaccharides induce antibody formation by human B lymphocytes in vitro. J. Immunol. 1985, 135, 1-4.
19. 19 Peeters, C.C.A.M., Tenbergen-Meekes, A.-M., Poolman, J.T., Zegers, B.J.M. and Rijkers, G.T. In vitro antibody response of human lymphocytes to the Haemophilus influenzae type b capsular polysaccharide. Springer Sem. Immunopathol. 1993, 15, 247-258.
20. 20 Feldman, R.G., Rijkers, G.T. and Zegers, B.J.M. Human B lymphocyte in vitro response to the Group B Streptococcal type III capsular carbohydrate. Scand. J. Immunol. 1993, 37, 343-348.
21. 21 Dillard, J.P., Vandersea, M.W. and Yother, J. Characterization of the cassette containing genes for type 3 capsular polysaccharide biosynthesis in Streptococcus pneumoniae. J. Exp. Med. 1995, 181, 973-983.
22. 22 Kolkman, M.A.B., Wakarchuk, W., van der Zeijst, B.A.M. and Nuijten, P.J.M. Capsular polysaccharide synthesis in Streptococcus pneumoniae serotype 14: molecular analysis of the complete cps locus and identification of genes encoding glycosyltransferases required for biosynthesis of the tetrasaccharide subunit. Mol. Microbiol. 1997, 26, 197-208.
23. 23 Morona, J.K., Morona, M. and Paton, J.C. Characterization of the locus encoding the Streptococcus pneumoniae type 19F capsular polysaccharide biosynthetic pathway. Mol. Microbiol. 1997, 23, 751-763.
24. 24 Muñoz, R., Mollerach, M., Löpez, R. and Garcia, E. Molecular organization of the genes required for the synthesis of type 1 capsular polysaccharide of Streptococcus pneumoniae: formation of binary encapsulated pneumococci and identification of cryptic dTDP-rhamnose biosynthesis genes. mol. Microbiol. 1997, 25, 79-92.
25. 25 Harding, C.V., Roof, R.W., Allen, P.W. and Unanue, E.R. Effects of pH and polysaccharides on peptide binding to class II major histocompatibility complex molecules. Proc. Natl Acad. Sci. USA 1991, 88, 2740-2744.
26. 26 Porcelli, S.A. and Brenner, M.B. Antigen presentation: mixing oil and water. Current Biol. 1997, 7, 508-511.
27. 27 Snapper, C.M., Rosas, F.R., Moorman, M.A. and Mond, J.J. Restoration of T cell-independent type 2 induction of Ig secretion by neonatal B cells in vitro. J. Immunol. 1997, 158, 2731-2735.
28. 28 Marshall-Clarke, S., Owen, G. and Tasker, L. Ligation of CD40 with soluble CD40 ligand reverses anti-immunoglobulin-mediated negative signalling in murine B lymphoma cell lines, but not in immature B cells from neonatal mice. Immunology 1996, 87, 624-632.
29. 29 Rijkers, G.T., Dollekamp, E.G. and Zegers, B.J.M. The in vitro response to pneumococcal polysaccharides in adults and neonates. Scand. J. Immunol. 1987, 25, 447-452.
30. 30 Timens, W.A., Bols, A., Uiterwijk-Rozeboom, T. and Poppema, S. Immaturity of the human splenic marginal zone in infancy. Possible contribution to the deficient infant immune response. J. Immunol. 1989, 143, 3200-3206.
31. 31 Dempsey, P.W., Allison, M.E.D., Akkaraju, S., Goodnow, C.C. and Fearon, D.T. C3d of complement as a molecular adjuvant bridging innate and acquired immunity. Science 1996, 271, 348-350.
32. 32 Griffioen, A.W., Rijkers, G.T., Janssens-Korpela, P. and Zegers, B.J.M. Pneumococcal polysaccharides complexed with C3d bind to human B lymphocytes via complement receptor type 2. Infect. Immun. 1991, 59, 1839-1845.
33. 33 Griffioen, A.W., Toebes, E.A.M., Zegers, B.J.M. and Rijkers, G.T. Role of the CR2 in the human adult and neonatal in vitro antibody response to type 4 pneumococcal polysaccharide. Cell Immunol. 1992, 143, 11-22.
34. 34 Harms, G., Hardonk, M.J. and Timens, W. In vitro complement-dependent binding and in vivo kinetics of pneumococcal polysaccharide TI-2 antigens in the rat spleen marginal zone and follicle. Infect. Immunol. 1996, 64, 4220-4225.
35. 35 Peset Llopis, M.-J., Harms, G., Hardonk, M.J. and Timens, W. Human immune response to pneumococcal polysaccharides: complement-mediated localization preferentially on CD21-positive splenic marginal zone B cells and follicular dendritic cells. J. Allergy Clin. Immunol. 1996, 97, 1015-1024.
36. 36 Griffioen, A.W., Franklin, S.W., Zegers, B.J.M. and Rijkers, G.T. Expression and functional characteristics of the complement receptor type 2 on adult and neonatal B lymphocytes. Clin-Immunol. Immunopathol. 1993, 69, 1-8.
37. 37 Goebel, W.F. and Avery, O.T. Chemo-immunological studies on conjugated carbohydrate proteins. II. Immunological specificity of synthetic sugar proteins. J. Exp. Med. 1929, 50, 533-550.
38. 38 Ähman, H., Kahty, H. and Tamminnen, P. et al. Pentavalent pneumococcal oligosaccharide conjugate vaccine PnCRM is well tolerated and able to induce an antibody response in infants. Fed. Infect. Dis. J. 1996, 15, 134-139.
39. 39 Daum, R.S., Hogerman, D., Rennels, M.B., Bewley, K. and Malinoski, F. et al. Infant immunization with pneumococcal CRM197 vaccines: effect of saccharide size on immunogenicity and interaction with simultaneously administered vaccines. J. Infect. Dis. 1997, 176, 445-455.
40. + T lymphocytes in adults infected with human immundeficiency virus. Clin. Infect. Dis. 1997, 25, 600-606.
41. 41 Freijd, A., Hämmarström, L., Persson, M.A.A. and Smith, C.I.E. Plasma anti-pneumococcal antibody activity of the IgG class and subclasses in otitis prone children. Clin. Exp. Immunol. 1984, 56, 233-238.
42. 42 Lortan, J.E., Kaniuk, A.St.C. and Monteil, M.A. Relationship of in vitro phagocytosis of serotype 14 Streptococcus pneumoniae to specific class and IgG subclass antibody levels in healthy adults. Clin. Exp. Immunol. 1993, 91, 54-57.
43. 43 Sanders, E.A.M., Rijkers, G.T., Tenbergen-Meekes, A.M., Voorhorst-Ogink, M.M. and Zegers, B.J.M. Immunoglobulin isotype specific antibody responses to pneumococcal polysaccharide vaccine in patients with recurrent respiratory tract infections. Ped. Res. 1995, 37, 812-819.
44. 44 O'Brien, K.L., Steinhoff, M.C., Edwards, K., Keyserling, H., Thomas, M.L. and Madore, D. Immunologic priming of young children by pneumococcal glycoprotein conjugate, but not polysaccharide vaccines. Ped. Infect. Dis. J. 1996, 15, 425-430.